Mark Andrews

GHS Managing Director

Mark Andrews is a seasoned executive with over 25 years of leadership experience, including nearly two decades in the South African pharmaceutical sector. A growth architect and operational strategist, Mark has consistently delivered revenue acceleration, business transformation, and commercial innovation across diverse industries, from pharma to manufacturing and consulting.

Most recently he served as Managing Director of BFC Pharma, leading full P&L, strategic direction, and product pipeline development. Under his leadership, the company designed and launched over 58 new products across the 2024–2025 period, while strengthening its market presence in pharmacy channels nationwide.

Mark’s leadership spans strategic business modelling, sales force effectiveness, go-to-market execution, and stakeholder alignment – including BEE partnerships to unlock public-sector growth. His ability to lead large teams, drive complex negotiations, and deliver both top- and bottom-line results, positions him as a key executive powering business scale and resilience.

Home

Overview of Luro Investments

About

Our team, vision & values

Generation Health Solutions

SA + Global Innovation

Lucca Actives

SA + UK Specialised Actives

Symbiochem

SA + EU Chemical Solutions

Wellness Alchemy

Premium Nutritional Brands

Probitec

Targeted Microbiome Support

WagLife

Veterinary Pet Nutrition

Traders of Goodness

Ethical Sourcing & Trade

Contact

Send us a message